Acura Pharmaceuticals Price to Sales Ratio 2012-2021 | ACUR
Historical PS ratio values for Acura Pharmaceuticals (ACUR) over the last 10 years. The current P/S ratio for Acura Pharmaceuticals as of June 19, 2026 is .
| Acura Pharmaceuticals P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-06-17 | 0.00 | 0.01 | |
| 2021-12-31 | 0.50 | $0.04 | 13.04 |
| 2021-09-30 | 0.53 | $0.06 | 8.79 |
| 2021-06-30 | 0.66 | $0.07 | 9.56 |
| 2021-03-31 | 0.33 | $0.10 | 3.43 |
| 2020-12-31 | 0.21 | $0.11 | 1.90 |
| 2020-09-30 | 0.25 | $0.13 | 1.87 |
| 2020-06-30 | 0.35 | $0.16 | 2.15 |
| 2020-03-31 | 0.28 | $0.12 | 2.27 |
| 2019-12-31 | 0.23 | $0.09 | 2.48 |
| 2019-09-30 | 0.30 | $0.05 | 5.99 |
| 2019-06-30 | 0.14 | $0.01 | 12.16 |
| 2019-03-31 | 0.18 | $0.01 | 13.77 |
| 2018-12-31 | 0.11 | $0.02 | 5.91 |
| 2018-09-30 | 0.19 | $0.02 | 9.16 |
| 2018-06-30 | 0.36 | $0.02 | 15.94 |
| 2018-03-31 | 0.51 | $0.03 | 19.08 |
| 2017-12-31 | 0.40 | $0.24 | 1.67 |
| 2017-09-30 | 0.45 | $0.55 | 0.80 |
| 2017-06-30 | 0.56 | $0.57 | 0.99 |
| 2017-03-31 | 0.60 | $0.58 | 1.03 |
| 2016-12-31 | 0.77 | $0.38 | 2.04 |
| 2016-09-30 | 1.60 | $0.31 | 5.21 |
| 2016-06-30 | 1.85 | $0.31 | 6.03 |
| 2016-03-31 | 2.83 | $0.32 | 8.85 |
| 2015-12-31 | 2.50 | $0.84 | 2.96 |
| 2015-09-30 | 2.35 | $0.65 | 3.62 |
| 2015-06-30 | 4.94 | $0.65 | 7.64 |
| 2015-03-31 | 3.95 | $0.62 | 6.42 |
| 2014-12-31 | 2.25 | $0.08 | 29.30 |
| 2014-09-30 | 3.92 | $0.03 | 148.68 |
| 2014-06-30 | 5.45 | $0.02 | 268.60 |
| 2014-03-31 | 7.30 | $0.02 | 434.17 |
| 2013-12-31 | 8.35 | $0.01 | 645.15 |
| 2013-09-30 | 9.50 | $0.01 | 0.00 |
| 2013-06-30 | 9.40 | $0.00 | 0.00 |
| 2013-03-31 | 10.65 | $0.00 | 0.00 |
| 2012-12-31 | 11.10 | 0 | 0.00 |
| 2012-09-30 | 8.70 | 0 | 0.00 |
| 2012-06-30 | 15.70 | 0 | 0.00 |
| 2012-03-31 | 17.30 | $2.11 | 8.21 |
| 2011-12-31 | 17.45 | $2.13 | 8.18 |
| 2011-09-30 | 17.00 | $2.17 | 7.83 |
| 2011-06-30 | 19.35 | $2.20 | 8.79 |
| 2011-03-31 | 15.80 | $0.16 | 98.81 |
| 2010-12-31 | 16.55 | $0.35 | 46.91 |
| 2010-09-30 | 12.45 | $0.40 | 31.42 |
| 2010-06-30 | 12.55 | $0.45 | 27.70 |
| 2010-03-31 | 26.95 | $0.49 | 55.56 |
| 2009-12-31 | 26.65 | $0.42 | 63.70 |
| 2009-09-30 | 25.55 | $1.12 | 22.72 |
| 2009-06-30 | 29.90 | $1.43 | 20.92 |
| 2009-03-31 | 32.10 | $2.86 | 11.23 |
| 2008-12-31 | 36.70 | $4.44 | 8.27 |
| 2008-09-30 | 35.15 | $3.65 | 9.63 |
| 2008-06-30 | 39.75 | $3.26 | 12.21 |
| 2008-03-31 | 43.70 | $1.73 | 25.29 |
| 2007-12-31 | 30.50 | 0 | 0.00 |
| 2007-09-30 | 84.00 | 0 | 0.00 |
| 2007-06-30 | 55.25 | 0 | 0.00 |
| 2007-03-31 | 42.50 | 0 | 0.00 |
| 2006-12-31 | 37.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |